PHARMADANICA A/S: Financial statements 2019
CVR: 19056007
Source: annual report 2019, Danish Business Authority
01/04/2018 – 31/03/2019
PHARMADANICA A/S (CVR 19056007) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK 3,325,178. Equity in the 2019 report amounted to DKK 19,649,369. The solvency ratio was 92.8%.
- Profit/Loss
- DKK 3,325,178
- Equity
- DKK 19,649,369
- Total Assets
- DKK 21,167,638
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | 3.3M | 19.6M | - |
| 2017 | - | - | 12.9M | 16.3M | - |
| 2016 | - | - | -18K | 3.5M | - |
| 2015 | - | - | 2.5M | 3.5M | - |
| 2014 | - | -21K | -40K | 989K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of February 13, 2019, Kim Erik Ginnerup has joined the board of directors of PHARMADANICA A/S.
As of February 13, 2019, Aymeric Erouart has joined the board of directors of PHARMADANICA A/S.
As of February 13, 2019, Annie Renée Simonne Dateu has joined the board of directors of PHARMADANICA A/S.
As of February 12, 2019, Kim Erik Ginnerup has left the board of directors of PHARMADANICA A/S.
About PHARMADANICA A/S
PHARMADANICA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named A/S PSE NR. 4943. The management consists of Jean-Marc Pierre Rene Leccia and Edouard Marc Marie Favreau. The board consists of Eric Pierre Jean Muris (chair), Kim Erik Ginnerup, Ilona Maureen Fischer and Jean-Marc Pierre Rene Leccia. The company is owned by MISSIONPHARMA A/S. The company has 3 employees (2004). In 2026, the company reported a net result of DKK 4,314,032 compared with DKK -339,647 the year before. Equity in the 2026 report amounted to DKK 20,960,385.